Source link : https://www.newshealth.biz/health-news/treatment-of-tardive-dyskinesia-medpage-today/
Experts and guidelines recommend vesicular monoamine 2 transporter (VMAT2) inhibitors as the best option for treating more severe cases of tardive dyskinesia, an involuntary movement disorder caused by dopamine-blocking drugs. The condition, which is usually irreversible, is most typically associated with sustained antipsychotic treatment. While weaning off the offending medication can resolve anywhere from 10-30% […]
Author : News Health
Publish date : 2024-08-13 16:52:00
Copyright for syndicated content belongs to the linked Source.
Categories